Enlarge this image The “Medicaid Drug Decisions Transparency Act” would require pharmaceutical companies to disclose their payments to pharmacists and others who…
Pharmaceuticals
Pharmaceuticals
-
-
Enlarge this image Atorvastatin, the generic form of Lipitor, can reduce the chances of heart attacks and strokes in people at risk.…
-
Enlarge this image The Food and Drug Administration has seen a sharp increase in applications for drug to treat rare diseases. An…
-
News
Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
by Sarah Jane Tribble September 28, 2018Enlarge this image Purdue Pharma, maker of the opioid OxyContin, has a subsidiary that won a patent for a treatment for opioid…
-
News
New Medicare Advantage Tool To Control Drug Prices Could Narrow Choices
by Susan Jaffe September 13, 2018Enlarge this image Health insurers who offer Medicare Advantage plans have permission to soon require patients to try less expensive alternatives to…
-
News
A Setback For Massachusetts In States’ Drive To Contain Medicaid Drug Spending
by Martha Bebinger September 12, 2018Enlarge this image Massachusetts wanted to negotiate prices and stop the use of some of the most expensive drugs in its Medicaid…
-
News
Hospitals Prepare To Launch Their Own Drug Company To Fight High Prices And Shortages
by Alison Kodjak September 6, 2018Enlarge this image Intermountain Healthcare, whose Intermountain Medical Center Patient Tower in Murray, Utah, is seen here, is a leader in the…
-
News
Texas Tightens Disclosure Rules Following Medicaid Investigation
by Liz Essley Whyte August 17, 2018Enlarge this image Texas officials are requiring that people who comment at Medicaid meetings on pharmaceuticals disclose more details about their ties…